The current Managing Director of JEM Pharmaceuticals, John is a seasoned veteran of 30 years in the pharmaceutical and healthcare industry. He spent 15 years at Roche holding a number of senior commercial positions, around the world. John returned to Australia in 2005 to head Orphan Australia Pty Ltd. During his tenure, several products were in-licensed and profit increased by 105%. Orphan was subsequently sold for A$130M.
John founded JEM Pharmaceuticals, a company dedicated to commercialising new and novel products in Australia and ASIA. As the inaugural managing director, he established commercial operations for Teva Pharma Australia and manages both the Australian and New Zealand operations.